NantHealth’s Eviti Connect Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance
21 3월 2023 - 10:00PM
Business Wire
HITRUST Certification validates NantHealth’s
commitment to aligning with key regulations and protecting
sensitive information
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of
enterprise solutions transforming complex data into actionable
insights, today announced its Eviti Connect solution has earned
Certified status for information security by HITRUST.
HITRUST Risk-based, 2-year (r2) Certified status demonstrates
that NantHealth’s Eviti Connect solution has met key regulations
and industry-defined requirements for managing risk. This
achievement places NantHealth in an elite group of organizations
worldwide that have earned this certification.
“Organizations like ours are under continuous pressure to meet
complex compliance and privacy requirements that include both
technical and process elements,” said Ron Louks, Chief Operating
Officer at NantHealth. “We are excited to demonstrate to our
customers that we are committed to the highest standards for data
protection and information security by achieving HITRUST
Risk-based, 2-year Certification.”
By including federal and state regulations, standards and
frameworks, and incorporating a risk-based approach, the HITRUST
Assurance Program helps organizations address security and data
protection challenges through a comprehensive and flexible
framework of prescriptive and scalable security controls.
“In today’s ever-changing threat landscape, HITRUST is
continually innovating to find new and creative approaches to
address challenges,” said Jeremy Huval, Chief Innovation Officer,
HITRUST. “NantHealth’s Eviti Connect HITRUST Risk-based, 2-year
Certification is evidence that they are at the forefront of
industry best practices for information risk management and
compliance.”
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies,
provides enterprise solutions that help businesses transform
complex data into actionable insights. By offering efficient ways
to move, interpret and visualize complex and highly sensitive
information, NantHealth enables customers in healthcare, life
sciences, logistics, telecommunications and other industries to
automate, understand and act on data while keeping it secure and
scalable. NantHealth’s product portfolio comprises the latest
technology in payer/provider collaboration platforms for real-time
coverage decision support (Eviti and NaviNet), and data solutions
that provide multi-data analysis, reporting and professional
services offerings (Quadris). The OpenNMS Group, Inc., a NantHealth
subsidiary, helps businesses monitor and manage network health and
performance. For more information, visit nanthealth.com, follow us
on Twitter, Facebook, LinkedIn and YouTube, and subscribe to our
blog.
Forward Looking Statement
In addition to historical information, this Current Report on
Form 8-K contains or may imply forward-looking statements within
the meaning of the federal securities laws, such as any implication
regarding the Company’s EVITI Connect solution and expectations
regarding the Company’s opportunities related to achieving HITRUST
certification for Eviti Connect, including any anticipated
benefits, results and future opportunities related thereto. Such
forward-looking statements include projections regarding the
Company’s beliefs and expectations about future performance and, in
some cases, may be identified by words like "anticipate," "assume,"
"believe," "continue," "could," "estimate," "expect," "intend,"
"may," "plan," "potential," "predict," "project," "future," "will,"
"seek" and similar terms or phrases. These statements are based on
the Company’s beliefs and assumptions, which in turn are based on
information available as of the date of this Current Report on Form
8-K. Forward-looking statements involve known and unknown risks and
uncertainties, which could cause actual results to differ
materially from those contained in any forward-looking statement
and could harm the Company’s business, prospects, results of
operations, liquidity and financial condition and cause its stock
price to decline significantly. Many of these factors are beyond
the Company’s ability to control or predict. Important factors that
could cause the Company’s actual results to differ materially from
those indicated in the forward-looking statements include, among
others: the possibility that the conditions under the Credit
Agreement are not satisfied, including for reasons outside the
Company’s control, general economic conditions, including
inflation, recession, adverse developments affecting the financial
services industry, unemployment levels, spending patterns, credit
availability and debt levels, more stringent or costly payment
terms and/or the decision by a significant number of vendors not to
provide services to the Company on a timely basis or at all, the
ability to monetize the Company’s assets on acceptable terms, the
ability to implement the Company’s strategic plan, including any
potential restructuring initiatives, customer acceptance of the
Company’s strategies, the Company’s ability to attract, motivate
and retain key executives and other employees, the impact of cost
reduction initiatives if implemented, the Company’s ability to
generate or maintain liquidity, the Company’s shares are delisted
from the Nasdaq Global Select Market, potential litigation relating
to the Credit Agreement, risks relating to the substantial costs
and diversion of personnel’s attention and resources due to these
matters and other factors discussed in greater detail in the
sections titled "Risk Factors" in the Company’s most recent Annual
Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q
and in other documents filed or furnished with the Securities and
Exchange Commission. As a result of these factors, actual results
may differ materially from those indicated or implied by
forward-looking statements. Given these uncertainties, you should
not place undue reliance on these forward-looking statements. These
forward-looking statements are made only as of the date hereof and
the Company undertakes no obligation to update or revise publicly
any forward-looking statements, except as required by law. New
factors emerge from time to time, and it is not possible for us to
predict all such factors.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230321005523/en/
Jen Hodson Jen@nant.com 562-397-3639
NantHealth (NASDAQ:NH)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
NantHealth (NASDAQ:NH)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024